• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, December 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Nerve growth factor: Early studies and recent clinical trials

Bioengineer by Bioengineer
January 18, 2019
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Luigi Aloe et al. is published in Current Neuropharmacology, Volume 16 , Issue 10 , 2018

Nerve growth factor has been playing an important role in development of adult neurobiology. This is because of the regulatory functions that it possesses on survival, growth and differentiation of nerve cells in both of the central and peripheral nervous systems. Nerve growth factor plays an action in survival and growth of peripheral, sympathetic and sensory neurons along on numerous amounts of brain neurons. As far as neuropathic factors are concerned, NGF is the first discovered member of a family collectively indicated as neurotrophins. This includes, brain derived neurophin 4/5, neurotrophin-3 and nuerotrophic factor. For the sake of survival and differentiation of much selected population of peripheral neurons, NGF was discovered. Therefore, many studies took place to identify the role of purified NGF just for the sake of prevention of deaths of NGF-receptive cells. After all the studies, it was revealed to the researchers that NGF possesses good amount of therapeutic properties for diseases like, cutaneous ulcer, corneal ulcers, glaucoma, retinal maculopathy, Retinitis Pigmentosa along with optic gliomas and brain traumas.

Therefore, the researches and studies that took place on NGF showed new routes for the diagnostics along with that allowed safe amount of dosages to the effected patients. This thing widened the spectrum of therapy with the help of NGF based therapy.

###

Media Contact
Faizan ul Haq
[email protected]
http://dx.doi.org/10.2174/1570159X16666180412092859

Tags: Clinical TrialsInternal MedicineMedicine/HealthneurobiologyPharmaceutical Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Zinc Oxide Resveratrol Nanoparticles Protect Liver from Levofloxacin

December 26, 2025

Linking Triglyceride Glucose Index to DVT Post-Knee Surgery

December 26, 2025

Obacunone Reduces Polycystic Ovary Syndrome via STAT3 Inhibition

December 26, 2025

Evaluating Evidence Behind STOPP/START Version 3 Criteria

December 26, 2025
Please login to join discussion

POPULAR NEWS

  • Nurses’ Views on Online Learning: Effects on Performance

    Nurses’ Views on Online Learning: Effects on Performance

    70 shares
    Share 28 Tweet 18
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    71 shares
    Share 28 Tweet 18
  • Unraveling Levofloxacin’s Impact on Brain Function

    54 shares
    Share 22 Tweet 14
  • Exploring Audiology Accessibility in Johannesburg, South Africa

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

AKR1C1’s Crucial Role in Pancreatic Cancer Progression

DLK1-MEG3 Methylation Linked to Small Gestational Age

Rethinking Steroid Use in Cancer Treatment

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.